REBECCA SMITH: Open Payments
NPI 1396470423 · BIRMINGHAM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$394 in 15 payments from 7 companies in 2025. Trend: 2023 $20 · 2024 $14 · 2025 $394
Food & beverage: $304Education: $90
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 3 | $128 |
| ABBVIE INC. | 4 | $89 |
| AstraZeneca Pharmaceuticals LP | 2 | $45 |
| MOTIVA USA, LLC | 2 | $41 |
| Atland Pharmaceuticals, LLC | 1 | $40 |
| PFIZER INC. | 2 | $33 |
| UCB, Inc. | 1 | $17 |
Products named: TREMFYA, SKYRIZI, SAPHNELO, Motiva Implant Matrix, RINVOQ, ORPHENADRINE CITRATE, ASPIRIN AND CAFFEINE, XELJANZ, SIMPONI ARIA.
Industry payments across AL — which companies pay providers there.
